Insider · CIK 0001599522
Michal Handerhan
Files at BTCS (BTCS Inc.). First filing May 12, 2025, latest Jul 18, 2025.
Michal Handerhan files SEC Form 4 as COO, director and 10% owner at BTCS (BTCS Inc.). Since May 12, 2025, Michal Handerhan has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.7M, the latest filed on Jul 18, 2025.
A track record needs three past buys with six months of prices behind them; Michal Handerhan has 0, so none is measured yet.
The newest scored trade: sold $677k of BTCS on Jul 16, 2025, filed Jul 18, 2025, scored 20 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BTCS: BTCS Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | BTCS Inc. | $677k 112,779 shares | -6% | +443% from low-3% from high | |
| 3Weak | BTCS Inc. | $527k 87,221 shares | -5% | +458% from low0% from high | |
| 17Weak | BTCS Inc. | $450k 150,000 shares | -9% | +193% from low-36% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 21, 2025 | BTCS BTCS Inc. | 400,000 1.90% of outstanding | $4.0M | Jul 18, 2025 | $1.7M |
| Jul 8, 2025 | BTCS BTCS Inc. | 200,000 0.95% of outstanding | $560k | Jul 8, 2025 | $450k |
| Feb 27, 2025 | BTCS BTCS Inc. | 750,000 3.95% of outstanding | $5.7M | Mar 5, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | BTCS BTCS Inc. | DDisposition to issuer Common Stock | -333,333 | $0.00 | $0 | 1,308,248 | Aug 19, 2025 |
| Jul 16, 2025 | BTCS BTCS Inc. | SOpen-market sale Common Stock10b5-1 | -112,779 | $6.00 | $677k | 1,641,581 | Jul 18, 2025 |
| Jul 8, 2025 | BTCS BTCS Inc. | SOpen-market sale Common Stock10b5-1 | -87,221 | $6.04 | $527k | 1,516,881 | Jul 10, 2025 |
| Jul 9, 2025 | BTCS BTCS Inc. | MOption exercise Common Stock10b5-1 | +237,479 | $1.90 | $451k | 1,754,360 | Jul 10, 2025 |
| Jul 9, 2025 | BTCS BTCS Inc. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -350,000 | - | - | 0 | Jul 10, 2025 |
| May 9, 2025 | BTCS BTCS Inc. | SOpen-market sale Common Stock10b5-1 | -150,000 | $3.00 | $450k | 1,604,102 | May 12, 2025 |
| Jan 1, 2025 | BTCS BTCS Inc. | AGrant or award Common Stock | +153,322 | - | - | 1,787,833 | Jan 6, 2025 |
| Jan 1, 2025 | BTCS BTCS Inc. | FTax withholding Common Stock | -33,731 | - | - | 1,754,102 | Jan 6, 2025 |
| Jan 1, 2025 | BTCS BTCS Inc. | AGrant or award Stock Options (Right to Buy)derivative | +86,244 | $0.00 | $0 | 86,244 | Jan 6, 2025 |
| Dec 12, 2024 | BTCS BTCS Inc. | FTax withholding Common Stock | -24,445 | $3.28 | $80k | 1,634,511 | Dec 16, 2024 |
Questions about Michal Handerhan
Answered from the filings on this page, as of the latest one.
Is Michal Handerhan buying or selling?
Not in the last 12 months. Michal Handerhan's latest open-market trade on SEC Form 4 was sold $677k of BTCS on Jul 16, 2025.
How did Michal Handerhan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michal Handerhan has 0.
Where does Michal Handerhan file Form 4?
Michal Handerhan has filed Form 4 at BTCS (BTCS Inc.) as COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.